Wijnands M - Search Results

1

Longterm treatment with nonsteroidal antiinflammatory drugs in rheumatoid arthritis: a prospective drug survival study.

Wijnands M, van Riel P, van 't Hof M, Gribnau F, van de Putte L. Wijnands M, et al. J Rheumatol. 1991 Feb;18(2):184-7. J Rheumatol. 1991. PMID: 2023212 Clinical Trial.

2

Mucocutaneous reactions to gold: a prospective study of 74 patients with rheumatoid arthritis.

van Gestel A, Koopman R, Wijnands M, van de Putte L, van Riel P. van Gestel A, et al. Among authors: wijnands m. J Rheumatol. 1994 Oct;21(10):1814-9. J Rheumatol. 1994. PMID: 7837143

3

Long-term second-line treatment: a prospective drug survival study.

Wijnands MJ, van't Hof MA, van Leeuwen MA, van Rijswijk MH, van de Putte LB, van Riel PL. Wijnands MJ, et al. Br J Rheumatol. 1992 Apr;31(4):253-8. doi: 10.1093/rheumatology/31.4.253. Br J Rheumatol. 1992. PMID: 1348198

4

Hemolysis during low-dose sulfasalazine treatment in rheumatoid arthritis patients.

Wijnands MJ, Nuver-Zwart IH, van Riel PL, van 't Hof MA, Gribnau FW, van De Putte LB. Wijnands MJ, et al. Scand J Rheumatol. 1991;20(1):52-7. doi: 10.3109/03009749109165922. Scand J Rheumatol. 1991. PMID: 1672775 Clinical Trial. No abstract available.

5

Generalized urticarial eruption during azathioprine treatment for rheumatoid arthritis. A case report and review of the literature.

Wijnands MJ, Perret CM, van Riel PL, van de Putte LB. Wijnands MJ, et al. Scand J Rheumatol. 1990;19(2):167-9. doi: 10.3109/03009749009102122. Scand J Rheumatol. 1990. PMID: 2186478 Review. No abstract available.

6

Risk factors of second-line antirheumatic drugs in rheumatoid arthritis.

Wijnands MJ, van Riel PL, Gribnau FW, van de Putte LB. Wijnands MJ, et al. Semin Arthritis Rheum. 1990 Jun;19(6):337-52. doi: 10.1016/0049-0172(90)90071-m. Semin Arthritis Rheum. 1990. PMID: 2196675 Review. No abstract available.

7

Rheumatoid arthritis: a risk factor for sulphasalazine toxicity? A meta-analysis.

Wijnands MJ, Van 'T Hof MA, Van De Putte LB, Van Riel PL. Wijnands MJ, et al. Br J Rheumatol. 1993 Apr;32(4):313-8. doi: 10.1093/rheumatology/32.4.313. Br J Rheumatol. 1993. PMID: 8096419

8

A prospective analysis of risk factors for the discontinuation of second-line antirheumatic drugs.

Wijnands MJ, Van 't Hof MA, Van Leeuwen MA, Van Rijswijk MH, Van de Putte LB, Van Riel PL. Wijnands MJ, et al. Pharm World Sci. 1993 Oct 15;15(5):203-7. doi: 10.1007/BF01880627. Pharm World Sci. 1993. PMID: 8257957

9

Thrombocytopenia due to aurothioglucose, sulphasalazine, and hydroxychloroquine.

Wijnands MJ, Allebes WA, Boerbooms AM, van de Putte LB, van Riel PL. Wijnands MJ, et al. Ann Rheum Dis. 1990 Oct;49(10):798-800. doi: 10.1136/ard.49.10.798. Ann Rheum Dis. 1990. PMID: 1978639 Free PMC article.

10

[Risk factors for the development of side effects during treatment of rheumatoid arthritis with second-line antirheumatic agents; a review of the literature].

Wijnands MJ, van Riel PL, Gribnau FW, van de Putte LB. Wijnands MJ, et al. Ned Tijdschr Geneeskd. 1990 Jul 21;134(29):1387-91. Ned Tijdschr Geneeskd. 1990. PMID: 2197565 Review. Dutch. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

47 results

Search Page

Filters